The corporate’s newest initiative consolidates its ladies’s healthcare portfolio underneath a single id: i-choose. This vary contains interval panties, menstrual cups, and being pregnant take a look at kits. Its star product within the section, the i-pill emergency contraceptive, stays on the Nationwide Pharmaceutical Pricing Authority’s (NPPA) important medication listing, which caps costs. This value management mechanism, applied in March 2024, impacted its FY25 revenues, the corporate mentioned.